Literature DB >> 1928066

Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network.

J C Jennette1, J Wieslander, R Tuttle, R J Falk.   

Abstract

IgA nephropathy is a common form of glomerulonephritis that has varied clinical expressions, ranging from asymptomatic hematuria to rapidly progressive nephritis. We report the strong association (P less than 0.0001) of circulating IgA-fibronectin aggregates with IgA nephropathy. Of 30 patients with IgA nephropathy, 93.3% had serum IgA-fibronectin aggregates detected with an enzyme immunoassay using collagen as a substrate to bind the aggregates. Among the patients with IgA-fibronectin aggregates were patients with Henoch-Schönlein purpura and recurrent crescentic IgA nephropathy in transplants. Only 11.7% of 103 patients with other types of glomerular disease and 6.7% of normal controls had positive IgA-fibronectin aggregate assay levels. IgA-fibronectin aggregates also were detected in serum using an antifibronectin antibody capture assay; and could be depleted from serum by heparin-agarose affinity chromatography. The circulating IgA-fibronectin aggregates had the same unusual predominance of lambda relative to kappa light chains that is observed in the glomerular deposits of IgA nephropathy. The data indicate that IgA-fibronectin aggregates are a useful serologic marker for IgA nephropathy, Henoch-Schönlein purpura, and recurrent IgA nephropathy in transplants. The presence of fibronectin in the circulating aggregates may play an important role in the preferential deposition of nephritogenic IgA-containing immune complexes in the mesangium of patients with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928066     DOI: 10.1016/s0272-6386(12)80115-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

Review 1.  Autoimmunity and glomerulonephritis.

Authors:  R Saxena; C Johansson; P Bygren; J Wieslander
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Severe gastrointestinal vasculitis in Henoch-Schoenlein purpura: pathophysiologic mechanisms, the diagnostic value of factor XIII, and therapeutic options.

Authors:  Jae Il Shin; Jae Seung Lee
Journal:  Eur J Pediatr       Date:  2007-02-27       Impact factor: 3.183

3.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

Review 4.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

5.  Alteration of lung diffusion capacity in IgA nephropathy.

Authors:  S Ravilly; M Chaussain; J L Iniguez; A Lenhert; G Kalifa; P Brun; P Niaudet; D Gendrel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

6.  A case report suggesting a common pathogenesis for IgA nephropathy and Henoch-Schönlein purpura.

Authors:  K Kaneko; Y Suzuki; K Kiya; Y Fukuda; K Yabuta
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

7.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  Human anti-fibronectin antibodies in systemic lupus erythematosus: occurrence and antigenic specificity.

Authors:  M S Atta; R J Powell; N D Hopkinson; I Todd
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.

Authors:  Jien-Wen Chien; Woan-Ling Chen; Yi-Giien Tsui; Min-Chun Lee; An-Yi Lin; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2006-03-10       Impact factor: 3.714

10.  Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.

Authors:  Lijun Xu; Bingyu Li; Mengwen Huang; Kun Xie; Dong Li; You Li; Hua Gu; Jianmin Fang
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.